Chemotherapy-induced peripheral neurotoxicity, Nature Reviews Neurology, vol.60, issue.12, pp.657-66, 2010. ,
DOI : 10.1038/nrneurol.2010.160
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study, The Lancet Oncology, vol.12, issue.5, pp.431-471, 2011. ,
DOI : 10.1016/S1470-2045(11)70081-X
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues, The Lancet Oncology, vol.11, issue.11, pp.1086-95, 2010. ,
DOI : 10.1016/S1470-2045(10)70068-1
Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations, Haematologica, vol.95, issue.2, pp.311-320, 2010. ,
DOI : 10.3324/haematol.2009.012674
Management of treatment-emergent peripheral neuropathy in multiple myeloma, Leukemia, vol.27, issue.4, pp.595-608, 2012. ,
DOI : 10.1182/blood-2010-05-285155
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.24, issue.suppl 6, pp.133-140, 2013. ,
DOI : 10.1093/annonc/mdt297
Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma, Journal of Clinical Oncology, vol.29, issue.7, pp.797-804, 2011. ,
DOI : 10.1200/JCO.2010.28.0792
Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients, Haematologica, vol.96, issue.11, pp.1728-1760, 2011. ,
DOI : 10.3324/haematol.2011.041434
Genetic variation associated with bortezomib-induced peripheral neuropathy, Pharmacogenetics and Genomics, vol.21, issue.3, pp.121-130, 2011. ,
DOI : 10.1097/FPC.0b013e3283436b45
Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial, The Lancet Oncology, vol.11, issue.11, pp.1057-65, 2010. ,
DOI : 10.1016/S1470-2045(10)70206-0
A new multipoint method for genome-wide association studies by imputation of genotypes, Nature Genetics, vol.164, issue.7, pp.906-919, 2007. ,
DOI : 10.1038/nrg1916
SNiPA: an interactive, genetic variant-centered annotation browser, Bioinformatics, vol.31, issue.8, pp.1334-1340, 2015. ,
DOI : 10.1093/bioinformatics/btu779
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans, Science, vol.348, issue.6235, pp.648-60, 2015. ,
DOI : 10.1126/science.1262110
Mapping cis- and trans-regulatory effects across multiple tissues in twins, Nature Genetics, vol.44, issue.10, pp.1084-1093, 2012. ,
DOI : 10.1002/gepi.20533
Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival, BMC Medicine, vol.88, issue.2, pp.26-36, 2008. ,
DOI : 10.1182/blood-2002-08-2640
Genome-Wide Association Study: A Useful Tool to Identify Common Genetic Variants Associated with Drug Toxicity and Efficacy in Cancer Pharmacogenomics, Clinical Cancer Research, vol.20, issue.10, pp.2541-52, 2014. ,
DOI : 10.1158/1078-0432.CCR-13-2755
Genome-wide association studies: theoretical and practical concerns, American Association for Cancer Research. clincancerres.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited, pp.109-127, 2005. ,
DOI : 10.1093/jnci/djh075